Novel derivatives of 1,3-diphenoxypropane-2-on, process of their
申请人:Klingepharma GmbH & Co.
公开号:US04189594A1
公开(公告)日:1980-02-19
Compounds of the formula ##STR1## wherein R.sup.1 is Cl, Br, CH(CH.sub.3).sub.2 or C(CH.sub.3).sub.3 ; A is a single bond, --CH.dbd.CH-- or --CH.sub.2 --CH.sub.2 --; and R.sup.2 is H, the cation of a pharmaceutically acceptable salt or an alkyl of up to three carbons, are strong hypolipaemic agents.